title: The management of depression: the implications for managed care--roundtable discussion: Part 1.
abstract: Depression affects not only the patient and the provider, but the employer as well. Up to 25% of all women experience major depressive disorder, compared with perhaps as many as 12% of all men. It is highly prevalent in patients with other acute and chronic disease. On October 4, 1999, a panel of managed care medical directors, pharmacy directors, clinicians, researchers, and health economists was convened in San Diego to discuss the optimal treatment of the disorder. This roundtable discussion is presented in three parts. The first portion lays the clinical foundation for the management of this critical disorder.
authors.forename: J
authors.initials: J
authors.lastname: Kelsey
authors.forename: M
authors.initials: M
authors.lastname: Vodoor
authors.forename: E
authors.initials: E
authors.lastname: Hunkeler
authors.forename: M
authors.initials: M
authors.lastname: Zarr
authors.forename: J
authors.initials: J
authors.lastname: Mason
mesh_terms: D000928:Antidepressive Agents / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors; D014481:United States / Q000453:epidemiology
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors